Table 1 Baseline and demographic patients’ characteristics
Variable | GDHT group (n = 64) | Usual care group (n = 64) |
|---|---|---|
Age (years), mean ± SD | 66 ± 12 | 68 ± 11 |
BMI (kg/m2), median (IQR) | 25 (21–31) | 25 (21–30) |
Sex (male), n (%) | 32 (50%) | 37 (58%) |
Race (white), n (%) | 48 (75%) | 52 (81%) |
Charlson scorea, median (IQR) | 5 (4–6) | 6 (5–8) |
ECOG scoreb, n (%) | ||
0 | 29 (47%) | 26 (43%) |
1 | 19 (31%) | 19 (32%) |
2 | 6 (10%) | 8 (13%) |
3 | 8 (13%) | 6 (10%) |
4 | 0 | 1 (2%) |
Karnofsky scorec, median (IQR) | 90 (80–100) | 90 (80–100) |
Neoplasm, n (%) | ||
Stomach | 0 | 1 (2%) |
Esophagus | 9 (13%) | 6 (10%) |
Colon–rectus | 8 (13%) | 6 (10%) |
Gynecological | 18 (30%) | 21 (34%) |
Pancreas | 9 (15%) | 9 (15%) |
Liver | 6 (10%) | 2 (3%) |
Prostate | 6 (10%) | 8 (13%) |
Kidney | 4 (7%) | 5 (8%) |
Others | 1 (2%) | 3 (5%) |
Recent chemotherapy, n (%) | 3 (5%) | 1 (2%) |
Recent radiotherapy, n (%) | 0 | 0 |
Smokers, n (%) | ||
No | 41 (64%) | 41 (64%) |
Yes | 9 (14%) | 7 (11%) |
Previously | 14 (22%) | 16 (25%) |
Alcoholism, n (%) | ||
No | 56 (88%) | 55 (86%) |
Yes | 4 (6%) | 2 (33%) |
Previously | 4 (6%) | 7 (11%) |
Hypertension, n (%) | 38 (59%) | 35 (55%) |
Diabetes mellitus, n (%) | 12 (19%) | 16 (25%) |
Heart failure, n (%) | 2 (3%) | 3 (5%) |
Chronic obstructive pulmonary disease, n (%) | 4 (6%) | 6 (9%) |
Chronic kidney disease, n (%) | 2 (3%) | 6 (9%) |
Hypothyroidism, n (%) | 5 (8%) | 4 (6%) |
Stroke, n (%) | 0 | 6 (9%) |
Acute myocardial infarction, n (%) | 4 (6%) | 5 (8%) |
Pulmonary embolism/deep vein thrombosis, n (%) | 0 | 1 (2%) |